Can Stem Cells Ameliorate the Pancreatic Damage Induced by Streptozotocin in Rats?
Conclusions Bone marrow–derived MSCs have the capacity to differentiate into IPCs capable of controlling the blood glucose level in rats with STZ-induced diabetes. Furthermore, treatment with MSCs and IPCs can improve aberrant biochemical parameters in an STZ-induced diabetes model.
Source: Canadian Journal of Diabetes - Category: Endocrinology Source Type: research
More News: Cholesterol | Diabetes | Diabetes Mellitus | Endocrinology | Gastroschisis Repair | Insulin | Liver | Pancreas | Stem Cell Therapy | Stem Cells | Study | Urology & Nephrology